Free Trial

Deerfield Management Company L.P. Series C Has $30.51 Million Stock Holdings in DocGo Inc. (NASDAQ:DCGO)

DocGo logo with Medical background

Deerfield Management Company L.P. Series C cut its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 20.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,195,956 shares of the company's stock after selling 1,870,182 shares during the period. Deerfield Management Company L.P. Series C owned 7.05% of DocGo worth $30,511,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in DocGo by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 5,014,375 shares of the company's stock worth $21,261,000 after purchasing an additional 14,454 shares during the last quarter. WCM Investment Management LLC boosted its position in DocGo by 64.2% in the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company's stock worth $18,637,000 after purchasing an additional 1,687,100 shares during the last quarter. Northern Trust Corp raised its stake in shares of DocGo by 24.9% during the 4th quarter. Northern Trust Corp now owns 1,606,139 shares of the company's stock worth $6,810,000 after purchasing an additional 320,133 shares during the period. Franklin Resources Inc. increased its holdings in DocGo by 14.3% during the fourth quarter. Franklin Resources Inc. now owns 1,370,819 shares of the company's stock worth $5,812,000 after buying an additional 171,733 shares during the last quarter. Finally, Harbor Capital Advisors Inc. increased its stake in shares of DocGo by 37.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock worth $5,647,000 after purchasing an additional 363,391 shares during the last quarter. Institutional investors own 56.44% of the company's stock.

DocGo Stock Up 2.6 %

DocGo stock opened at $2.40 on Thursday. The firm has a fifty day simple moving average of $2.56 and a two-hundred day simple moving average of $3.70. DocGo Inc. has a twelve month low of $2.02 and a twelve month high of $5.68. The company has a market capitalization of $244.76 million, a PE ratio of 8.57, a P/E/G ratio of 14.16 and a beta of 1.14.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a "buy" rating to a "hold" rating and cut their target price for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus decreased their target price on DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $4.00 price target on shares of DocGo in a research report on Tuesday, April 8th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $4.89.

Read Our Latest Stock Analysis on DocGo

About DocGo

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Articles

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines